Alamar Biosciences (ALMR) vs Standard BioTools (LAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alamar Biosciences is the larger company by market cap ($1.78 billion vs $255.1 million), about 7.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | LAB |
|---|---|---|
| Share price | $25.62 | $0.6497 |
| Market cap | $1.78B | $255.06M |
| 1-day change | -7.74% | -4.27% |
| YTD return | — | -46.98% |
| 1-year return | — | -47.79% |
| 5-year return | — | -87.29% |
| EPS (TTM) | $-1.20 | $-0.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $39.61 | $1.72 |
| 52-week low | $18.85 | $0.63 |
| Distance from 52-week high | -35.32% | -62.23% |
| Analyst consensus | buy | none |
| Avg. price target upside | +38.17% | +107.79% |
| Average volume | 399.23K | 1.57M |
| Shares outstanding | 69.39M | 392.58M |
| Employees | 286 | 385 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alamar Biosciences is about 7.0 times larger than Standard BioTools by market value ($1.78B vs $255.06M).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Standard BioTools
LAB stock →Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Industrials · Biotechnology: Laboratory Analytical Instruments · 385 employees
ALMR vs LAB FAQ
Which is bigger, Alamar Biosciences or Standard BioTools?
Alamar Biosciences (ALMR) is larger, with a market capitalization of $1.78B compared with $255.06M for Standard BioTools (LAB).
Are Alamar Biosciences and Standard BioTools in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.